Paul D. Rubin

Companies

• BioAge Labs, Inc.Chief Medical Officer Sep 25, 2024 to now¹
• Viridian Therapeutics, Inc.\DEEVP, Research & Development Feb 13, 2017 to Feb 8, 2019²
• XOMA Royalty CorpVP Clinical Dev. & CMO Jun 2, 2011 to Mar 22, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BLBioAge Labs, Inc. BIOA0 shares⁴Apr 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 1, 2026Sold 8,820 shares at $17.81 of BioAge Labs, Inc.⁴
• Apr 1, 2026Exercised options 3,383 shares at $6.57 of BioAge Labs, Inc.⁴
• Apr 1, 2026Exercised options 5,437 shares at $4.11 of BioAge Labs, Inc.⁴
• Mar 2, 2026Sold 7,433 shares at $20.30 of BioAge Labs, Inc.⁵
• Mar 2, 2026Exercised options 2,000 shares at $6.57 of BioAge Labs, Inc.⁵
• Mar 2, 2026Exercised options 5,433 shares at $4.11 of BioAge Labs, Inc.⁵
• Feb 2, 2026Sold 7,433 shares at $18.75 of BioAge Labs, Inc.⁶
• Feb 2, 2026Exercised options 2,000 shares at $6.57 of BioAge Labs, Inc.⁶
• Feb 2, 2026Exercised options 5,433 shares at $4.11 of BioAge Labs, Inc.⁶
• Jan 2, 2026Sold 7,433 shares at $12.85 of BioAge Labs, Inc.⁷
• Jan 2, 2026Exercised options 2,000 shares at $6.57 of BioAge Labs, Inc.⁷
• Jan 2, 2026Exercised options 5,433 shares at $4.11 of BioAge Labs, Inc.⁷
• Dec 9, 2025Sold 18,000 shares at $12.00 of BioAge Labs, Inc.⁸
• Dec 9, 2025Exercised options 18,000 shares at $6.57 of BioAge Labs, Inc.⁸
• Dec 4, 2025Sold 68,897 shares at $10.19 of BioAge Labs, Inc.⁹
• Dec 4, 2025Exercised options 68,897 shares at $4.11 of BioAge Labs, Inc.⁹